GlassScriptPhysician profile
Mija Khan
NPI 1740667070
$5,706.27
in general payments reported to CMS, 2019-2025
9 companies · $1,573 in 2025
The $1,573 reported for 2025 was more than what 81% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,181 · 2022: $1,568 · 2023: $566 · 2024: $818 · 2025: $1,573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,564 · Travel and Lodging: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,563.99 |
| Travel and Lodging | $393.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $1,845.04 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Davol INC. | $1,504.96 | 2022-2025 | Phasix Mesh, Galaflex, Surgiphor |
| Sientra, INC. | $1,377.38 | 2021-2023 | Sientra High Strength Cohesive Silicone Gel Breast Implant |
| Stryker Corporation | $411.10 | 2024 | 1788, Spy-Phi System, Dermacell |
| Integra Lifesciences Corporation | $236.60 | 2021-2022 | |
| Abbvie INC. | $215.54 | 2023-2025 | |
| Allergan, INC. | $59.72 | 2021-2022 | |
| Ambu INC. | $29.76 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $26.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mija Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.